In a move to grow and upgrade its circular and low carbon solutions business, chemical producer LyondellBasell is to acquire full ownership of plastic recycler APK in Merseburg, Germany. Closing of the transaction is subject to customary closing conditions. Financial details of the deal have not been disclosed.
Bora Pharmaceuticals, a Taiwan-headquartered contract development and manufacturing organization (CDMO), has completed the acquisition of Emergent BioSolutions' sterile manufacturing facility in Baltimore-Camden, Maryland, USA. The facility adds drug product fill/finish to Bora’s extensive biologics drug substance capabilities.
Eli Lilly has completed its acquisition of Morphic, is a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases. The $3.2 billion deal was initially agreed upon by the companies in July 2024.
Manuchar, a global chemical distributor with headquarters in Antwerp, Belgium, has agreed to acquire a majority stake in Chilean company Proquiel Químicos.
Major US drugmaker MSD is to pay up to $1.3 billion to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated diseases, from biotechnology company Curon Biopharmaceutical.
US-headquartered biotech firm Recursion has announced that it will acquire UK-based pharmatech Exscientia in an all-stock deal. The transaction, which is expected to close in early 2025, would provide the combined entity with approximately $850 million in cash to fund its operations for the next three years. Reuters reported that Recursion will pay $688 million for the acquisition of Exscientia.
French specialty chemicals producer SNF has agreed to acquire PfP Industries and Ace Fluid Solutions, two oil and gas fluids firms based in Texas, USA. The strategic acquisitions, SNP said, expands its offerings for the company’s upstream oil and gas customers. Financial terms of the transactions were not disclosed.
In a move to accelerate its expansion into the $15 billion global waterproofing tape market, US adhesives major H.B. Fuller has acquired HS Butyl, the UK’s largest manufacturer and distributor of butyl tapes for a wide variety of applications within the construction, infrastructure, automotive and renewable energy industries. Financial details of the transaction were not disclosed.
AbbVie has completed its acquisition of Cerevel Therapeutics. According to AbbVie, Cerevel's pipeline is highly complementary to its own existing neuroscience portfolio. The takeover was announced in December 2023.
Global specialty ingredients solution provider Barentz International recently announced the acquisition of Anshul Life Sciences in India, a specialty chemicals distributor that caters to regulated pharmaceuticals, food & nutraceuticals, and personal care markets.
Santa Clara, CA-based Agilent Technologies has signed a definitive agreement to acquire specialized contract development and manufacturing organization Biovectra from H.I.G. Capital in a move to expand its end-to-end biopharma solutions.
Honeywell and Air Products recently announced that Honeywell has agreed to acquire Air Products’ liquefied natural gas (LNG) process technology and equipment business for €1.67 billion ($1.81 billion) in an all-cash transaction. This represents approximately 13x the estimated 2024 EBITDA.
Syensqo has completed the acquisition of a controlling stake in Azerys, a specialist in rosemary extraction with assets in El Jadida, Morocco.
In a move to enter the activated carbon market for micropollutants removal, Finnish chemicals company Kemira has agreed to purchase Norit’s UK reactivation business from Purton Carbons. The deal is expected to close in the third quarter of2024. Financial details of the deal were not disclosed.
South Korea-headquartered contract development and manufacturing organization (CDMO) SK Bioscience plans to acquire a 60% stake in IDT Biologika, a German CDMO specialized in vaccines, gene and immune therapy and oncolytic viruses, from Klocke Group. Klocke will retain a 40% stake in IDT Biologika and thus remains the company's second-largest shareholder.
AbbVie has acquired Celsius Therapeutics, a privately held biotechnology company developing new therapies inflammatory diseases, for $250 million in cash. The transaction is subject to certain customary adjustments.
In a move to enhance its chemistry, manufacturing and controls (CMC) capabilities, UK-based process research and development contract research organization (CRO) CatSci has acquired chromatography provider Reach Separations. Financial details of the transaction were not disclosed.
DuPont has signed an agreement to acquire US medical device contract manufacturer Donatelle Plastics. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. Financial details of the deal were not disclosed.
Dow has signed an agreement to acquire US company Circulus, a recycler of plastic waste into post-consumer resin (PCR). The transaction includes two facilities, one in Ardmore, Oklahoma, and another in Arab, Alabama, with a total capacity of 50,000 metric tons per year. Dow expects the transaction to close in the third quarter of 2024, subject to customary regulatory approval.
Japan’s Shin-Etsu Chemical has made an offer to acquire all of the shares in its affiliate Mimasu Semiconductor Industry for ¥68.0 billion (approximately $430.9 million). Shin-Etsu will raise its stake in Mimasu to 100% from the current 43.87%. The tender offer will begin on June 21, with the aim of closing by the end of Aug. 5.
Zofingen, Switzerland-based contract development and manufacturing organization (CDMO) Siegfried has signed a binding agreement to acquire an early-phase CDMO site in Grafton, Wisconsin, US, from Curia. The transaction is expected to close by July 1, subject to customary closing conditions.
In a move to continue its geographical expansion, Hamburg-based German distributor Biesterfeld has acquired Aerontec, a South African supplier and distributor of advanced composite materials and related technology.
In a move to expand its expertise and business in silicone-coated healthcare products, Germany’s Wacker Chemie has acquired the manufacturing assets and know-how of US-based Bio Med Sciences. As part of the acquisition, a majority of Bio Med Sciences’ workforce will also move to Wacker, the company said. Financial details of the transaction were not disclosed.
LyondellBasell (LYB) has completed the acquisition of a 35% interest in Saudi Arabia-based National Petrochemical Industrial Company (Natpet) from Alujain. The transaction was announced in January of this year.
US oil and gas giant ConocoPhillips has reached a definitive agreement to acquire Marathon Oil for $22.5 billion, including net debt of $5.4 billion. The transaction, which is subject to the approval of Marathon Oil stockholders, regulatory clearance and other customary closing conditions, is expected to close in the fourth quarter of 2024.
US drugmaker Merck & Co. (MSD) has agreed to acquire privately held ophthalmology-focused biotechnology company Eyebiotech (EyeBio).
US healthcare giant Johnson & Johnson (J&J) agreed to acquire Yellow Jersey Therapeutics (YJT) from biotechnology company Numab Therapeutics in an all-cash transaction valued at approximately $1.25 billion, giving it worldwide rights to the novel, investigational bispecific antibody NM26.
Biogen and Human Immunology Biosciences (HI-Bio), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs), have entered into a definitive agreement. Biogen has agreed to acquire HI-Bio for $1.15 billion (€1.06 billion) upfront and up to $650 million (€600.5 million) in potential milestone payments.
Genmab has completed its $1.8 billion acquisition of ProfoundBio, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) and ADC technologies for the treatment of cancers.
H.B. Fuller Company, the biggest pureplay adhesives company in the world, has acquired ND Industries, a leading provider of specialty adhesives and fastener locking and sealing solutions serving customers in the automotive, electronics, aerospace, and other industries.
US specialty chemicals producer Ashland has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners. The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions. Financial details of the transaction were not given.
Ineos Oxide and LyondellBasell have completed the sale of LyondellBasell’s Ethylene Oxide & Derivatives (EO&D) business and associated production facilities located in Bayport, Texas to Ineos.
Swiss drugmaker Novartis agreed to acquire Mariana Oncology, a US biotechnology company based in Watertown, Massachusetts, that develops novel radioligand therapies (RLTs) for the treatment of cancer.
Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer therapeutics, and specializes in kinase biology.
Arkema agreed to acquire Dow’s flexible packaging laminating adhesives business, a leading producer in this market with annual sales of approximately $250 million (€233 million). This acquisition will expand Arkema’s flexible packaging solutions portfolio, positioning the group as a key player in the industry.
